Baumann KE et al. High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer. Gynecol Oncol 2023;179:97-105. Abstract

Francoeur AA et al. Endometrial cancer and obesity trends in the United States in the 21st century. ASCO 2024;Abstract 5507.

Gupta A et al. Sexual harassment, abuse, and discrimination in obstetrics and gynecology: A systematic review. JAMA Netw Open 2024;7(5):e2410706. Abstract

Lheureux S et al. Phase II randomized multi-centre study of neoadjuvant olaparib in patients with platinum sensitive relapsed high grade serous ovarian cancer: The NEO trial. ASCO 2024;Abstract 5506.

Moyett JM et al. Understanding the spectrum of malignant bowel obstructions in gynecologic cancers and the application of the Henry score. Gynecol Oncol 2023;174:114-20. Abstract

Nguyen NTT et al. Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort study. Int J Gynecol Cancer 2024;34(4):528-34. Abstract

Nogueira-Rodrigues A et al. Real world challenges and disparities in the systemic treatment of ovarian cancer. Gynecol Oncol 2024;185:180-5. Abstract

Rojas C et al. Vibostolimab coformulated with pembrolizumab (vibo/pembro) for previously treated advanced mismatch repair–deficient (dMMR) endometrial cancer: Results from cohort B1 of the phase 2 KEYVIBE-005 study. ASCO 2024;Abstract 5502.

Secord AA. The power of shared purpose: Shattered glass ceilings, sticky floors, and elephants in the room. Gynecol Oncol 2024;183:A4-6. Abstract

Suzuki Y et al. Long-term survival outcomes for hormonal therapy in premenopausal patients with clinical stage I endometrial cancer. ASCO 2024;Abstract 5508.

Walsh CS et al. Molecular testing for endometrial cancer: An SGO clinical practice statement. Gynecol Oncol 2023;168:48-55. Abstract